7 analysts have expressed a variety of opinions on Bioceres Crop Solutions (NASDAQ:BIOX) over the past quarter, offering a diverse set of opinions from bullish to bearish.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $12.43, a high estimate of $16.00, and a low estimate of $9.50. This current average has decreased by 22.65% from the previous average price target of $16.07.

Analyzing Analyst Ratings: A Detailed Breakdown

The perception of Bioceres Crop Solutions by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

For valuable insights into Bioceres Crop Solutions's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.

Stay up to date on Bioceres Crop Solutions analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

All You Need to Know About Bioceres Crop Solutions

Key Indicators: Bioceres Crop Solutions's Financial Health

Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.

Revenue Growth: Bioceres Crop Solutions's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 18.31%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.23%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): Bioceres Crop Solutions's ROE excels beyond industry benchmarks, reaching -0.49%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Bioceres Crop Solutions's ROA excels beyond industry benchmarks, reaching -0.18%. This signifies efficient management of assets and strong financial health.

Debt Management: Bioceres Crop Solutions's debt-to-equity ratio surpasses industry norms, standing at 0.86. This suggests the company carries a substantial amount of debt, posing potential financial challenges.

Analyst Ratings: What Are They?

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.